Innate Pharma SA reports annual operating revenue of 4.3 million euros for 2010

Strong cash position with 34.5 million euros in cash, cash equivalents and current financial instruments as at the end of 2010
- IFRS unaudited provisional data-

Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) announces an operating revenue of 4.3 million euros for the year 2010. Turnover for the year amounted 0.2 million euros.